Drew Ranieri

Stock Analyst at Morgan Stanley

(0.9)
# 2239
Out of 5,358 analysts
175
Total ratings
38.64%
Success rate
2.82%
Average return
21 Stocks
Name Action PT Current % Upside Ratings Updated
ORGO Organogenesis Holdin...
Maintains: Equal-Weight
4 6
3.03 98.02% 4 Mar 5, 2025
GMED Globus Medical
Upgrades: Overweight
83 100
59.89 66.97% 12 Dec 2, 2024
SYK Stryker
Upgrades: Overweight
370 445
384.01 15.88% 9 Dec 2, 2024
SIBN SI-BONE
Maintains: Overweight
21 19
18.92 0.42% 15 Aug 6, 2024
IART Integra Lifesciences
Maintains: Underweight
24 27
13.55 99.26% 13 Jul 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
6 8
5.81 37.69% 12 Jul 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
26 22
23.86 -7.8% 16 Jul 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
10 8
13.17 -39.26% 13 Jul 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
19 16
12.72 25.79% 8 Jul 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
75 83
20.95 293.79% 10 Dec 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underweight
10 8
n/a n/a 11 Nov 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
42 38
18.74 102.77% 9 Nov 2, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
88 96
70.5 36.17% 10 May 12, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underweight
28 26
12.44 109% 8 May 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
290 295
173.43 70.1% 2 Feb 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
236 280
122.78 128.05% 5 Jan 6, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
11 5
6.68 -25.15% 6 Nov 10, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
72 70
30.25 131.4% 4 Oct 11, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
62 54
n/a n/a 1 Jul 15, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
325 300
556.79 -46.12% 6 Apr 25, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
130 148
n/a n/a 1 Aug 2, 2021